These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11548118)

  • 1. Toxicokinetics of ochratoxin A in vervet monkeys (Cercopithecus aethiops).
    Stander MA; Nieuwoudt TW; Steyn PS; Shephard GS; Creppy EE; Sewram V
    Arch Toxicol; 2001 Jul; 75(5):262-9. PubMed ID: 11548118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of ochratoxin A and its metabolites in rats.
    Li S; Marquardt RR; Frohlich AA; Vitti TG; Crow G
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):82-90. PubMed ID: 9221827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicokinetics of ochratoxin A in rat following intratracheal administration.
    Breitholtz-Emanuelsson A; Fuchs R; Hult K
    Nat Toxins; 1995; 3(2):101-3. PubMed ID: 7613733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicokinetics of ochratoxin A in several species and its plasma-binding properties.
    Hagelberg S; Hult K; Fuchs R
    J Appl Toxicol; 1989 Apr; 9(2):91-6. PubMed ID: 2715571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ochratoxin A-induced tumor formation: is there a role of reactive ochratoxin A metabolites?
    Zepnik H; Pähler A; Schauer U; Dekant W
    Toxicol Sci; 2001 Jan; 59(1):59-67. PubMed ID: 11134544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of ochratoxin A metabolites and DNA-adducts in monkey kidney cells.
    Grosse Y; Baudrimont I; Castegnaro M; Betbeder AM; Creppy EE; Dirheimer G; Pfohl-Leszkowicz A
    Chem Biol Interact; 1995 Mar; 95(1-2):175-87. PubMed ID: 7697749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotransformation and nephrotoxicity of ochratoxin B in rats.
    Mally A; Keim-Heusler H; Amberg A; Kurz M; Zepnik H; Mantle P; Völkel W; Hard GC; Dekant W
    Toxicol Appl Pharmacol; 2005 Aug; 206(1):43-53. PubMed ID: 15963343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A different kinetic profile of ochratoxin A in mature male rats.
    Vettorazzi A; Gonzalez-Peñas E; Trocóniz IF; Arbillaga L; Corcuera LA; Gil AG; de Cerain AL
    Food Chem Toxicol; 2009 Aug; 47(8):1921-7. PubMed ID: 19445996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicokinetics of the mycotoxin ochratoxin A in F 344 rats after oral administration.
    Zepnik H; Völkel W; Dekant W
    Toxicol Appl Pharmacol; 2003 Oct; 192(1):36-44. PubMed ID: 14554101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in DNA, RNA and protein contents in liver and kidney of mice treated with ochratoxin and their amelioration by Emblica officinalis aqueous extract.
    Verma R; Chakraborty D
    Acta Pol Pharm; 2008; 65(1):3-9. PubMed ID: 18536167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in ochratoxin a toxicity in F344 rats after 7 and 21 days of daily oral administration.
    Pastor L; Vettorazzi A; Enciso JM; González-Peñas E; García-Jalón JA; Monreal JI; López de Cerain A
    Food Chem Toxicol; 2018 Jan; 111():363-373. PubMed ID: 29126803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabonomic study of ochratoxin a toxicity in rats after repeated administration: phenotypic anchoring enhances the ability for biomarker discovery.
    Sieber M; Wagner S; Rached E; Amberg A; Mally A; Dekant W
    Chem Res Toxicol; 2009 Jul; 22(7):1221-31. PubMed ID: 19610676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional, biochemical, and pathological effects of repeated oral administration of ochratoxin A to rats.
    Mally A; Völkel W; Amberg A; Kurz M; Wanek P; Eder E; Hard G; Dekant W
    Chem Res Toxicol; 2005 Aug; 18(8):1242-52. PubMed ID: 16097797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ochratoxin A: 13-week oral toxicity and cell proliferation in male F344/n rats.
    Rached E; Hard GC; Blumbach K; Weber K; Draheim R; Lutz WK; Ozden S; Steger U; Dekant W; Mally A
    Toxicol Sci; 2007 Jun; 97(2):288-98. PubMed ID: 17344223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue distribution of ochratoxin A as determined by HPLC and ELISA and histopathological effects in chickens.
    Biró K; Solti L; Barna-Vetró I; Bagó G; Glávits R; Szabó E; Fink-Gremmels J
    Avian Pathol; 2002 Apr; 31(2):141-8. PubMed ID: 12396358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of 14C-ochratoxin A and 14C-ochratoxin B in rats: a comparison based on whole-body autoradiography.
    Breitholtz Emanuelsson A; Fuchs R; Hult K; Appelgren LE
    IARC Sci Publ; 1991; (115):201-3. PubMed ID: 1820334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ochratoxin A from a toxicological perspective.
    Petzinger E; Ziegler K
    J Vet Pharmacol Ther; 2000 Apr; 23(2):91-8. PubMed ID: 10849253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of pharmacokinetic computerized simulations in toxicological approach of ochratoxin A.
    Galtier P; Charpenteau JL; Alvinerie M
    J Environ Pathol Toxicol Oncol; 1990; 10(1-2):74-8. PubMed ID: 2231318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ochratoxin A exposure biomarkers in the Czech Republic and comparison with foreign countries.
    Malir F; Ostry V; Pfohl-Leszkowicz A; Roubal T
    Biomarkers; 2012 Nov; 17(7):577-89. PubMed ID: 22642623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An approach to the toxicity and toxicokinetics of aflatoxin B1 and ochratoxin A after simultaneous oral administration to fasted F344 rats.
    Corcuera LA; Vettorazzi A; Arbillaga L; González-Peñas E; López de Cerain A
    Food Chem Toxicol; 2012 Oct; 50(10):3440-6. PubMed ID: 22771364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.